DIA 2024 Global Annual Meeting

Attending this event?

DIA 2024 Global Annual Meeting

9:00am PDT

92F: Toolkit Approach to Best Practices in Root Cause Analysis and CAPA Management Workshop TBD 93F: Leadership Bootcamp TBD

7:00pm PDT

DIA Annual Meeting Networking Reception - USS Midway USS Midway

7:00am PDT

Coffee and Light Refreshments Sails Pavilion

8:00am PDT

Opening Plenary and Keynote Address

10:00am PDT

Coffee Break Exhibit Hall

10:15am PDT

Appian Innovation Theater: AI in Life Sciences - Promise or Peril? Exhibit Hall Theater #2 Mendel AI Innovation Theater: RWD 2.0 - Decoding Patient Journeys at Scale through Clinical AI Exhibit Hall Theater #3 Taimei Technology Innovation Theater: Next-Gen Trials Platform: AI-Native, Collaboration-First, and Site Network Exhibit Hall Theater #1

11:00am PDT

Reporting of Pre-Market and Post-Market Safety Reports to FDA Adverse Event Reporting System (FAERS) Using ICH E2B R3 Standards TBD Risk Management in Advanced Device Technology Development TBD Machine Learning and Simulations to Facilitate Clinical Trials TBD Cloud-Driven Transformation: Empowering Pharma Industry and Regulators TBD The Intersection of Science, Ethics, and Participant Collaboration in Pediatric Rare Disease Product Development TBD GCP Renovation: How Will GCP Inspection Change in Europe, Japan, and the US? TBD China Town Hall TBD Modernizing CDER’s New Drugs Review Program (NDRP): A Progress Update TBD Regulatory Convergence for CMC Requirements: The Challenges and Benefits of a Single Global Dossier TBD Master Protocols: Integrating and Debating Clinical Trial Designs TBD Breaking Boundaries: Overcoming Policy Crosstalk and Globalization Barriers to Foster Innovation TBD From Intention to Action: Building Diversity, Equity, and Inclusion Initiatives to Create a Culture of Belonging TBD Navigating the Trusted, Responsible, and Ethical Horizon of Artificial Intelligence: Uniting Healthcare Perspectives TBD

12:00pm PDT

Rare Diseases Multistakeholder Collaboration Towards Regulatory Endorsed Innovative Clinical Development Approach TBD Luncheon Service Exhibit Hall

12:15pm PDT

Datacubed Health Innovation Theater: The Impact of Digital Tools on Pediatric and Elderly Clinical Trials Exhibit Hall Theater #2 RWS Innovation Theater: Accelerate Time-to-Market with Smart, Structured Content, Reuse, and AI Exhibit Hall Theater #1 Roundtable Discussion: The Interaction of Science, Ethics, and Patient Collaboration in Pediatric Rare Disease Product Development TBD Professional and Student Poster Session 1 Posters Exhibit Hall

12:45pm PDT

Digital Transformation: More Than Just Technology - Understanding How to Make it a Reality TBD

12:55pm PDT

Box Innovation Theater: From Data Chaos to Digital Clarity - Defining the Next Generation of Life Sciences with AI and eSignatures Exhibit Hall Theater #3 IQVIA Innovation Theater: Evolving Clinical Development Approach Amidst a Digital Transformation Wave Exhibit Hall Theater #1 PPD, part of Thermo Fisher Scientific Innovation Theater: Accelerating Drug Development Through the Convergence of Real-World Data (RWD) and Technology Exhibit Hall Theater #2

1:30pm PDT

AI Enhanced Contact Center: Risks to Consider for Medical and Patient Information Exchange TBD

1:35pm PDT

Deloitte Innovation Theater: Turning Vision into Reality - Realizing the Promise of Next-Gen Regulatory Intelligence Exhibit Hall Theater #1 Evernorth Health Services Innovation Theater: Analyzing Online Survey Responsiveness and Participation Exhibit Hall Theater #2 H1 Innovation Theather: Beyond the Numbers - Humanizing Data in Clinical Trials for Inclusive Healthcare Solutions Exhibit Hall Theater #3

2:15pm PDT

The Cost of Moving the Needle on Clinical Trial Representation: Strategies for Diversity Budget Planning and Resourcing TBD ICH M11 Protocol Template: A Global Solution for Global Drug Development TBD Innovative Approaches to the Design of Pediatric Development Programs: What’s New in the Use of Pediatric Extrapolation TBD Shifting Medical Writing Value Propositions with the Use of Technology Tools TBD Enhancing the Science of Patient Engagement and Patient Input: What's in the Future? TBD Having the End in Mind When Building Quality into Clinical Trials: A Regulatory and Industry Perspective TBD Comparative Perspectives on Regulating AI in Drug Development: US Versus EU TBD The State of Real-World Evidence for Regulatory Decision-Making: Views from FDA, EMA, and PMDA TBD Options to Consider When Balancing Risk, Timelines, Cost, and Patient Centricity While Meeting Project Optimus Guidelines TBD In Vitro Diagnostic/Companion Diagnostics Developments in the US and Impact on Global Programs TBD Innovation in Manufacturing Globally TBD Causal Inference Methodology in Drug Development TBD Interactive Safety Graphics in the Regulatory Decision-Making Process TBD Unveiling the Secrets of Success: An Executive Panel with Insights to Navigating your Career Journey TBD

3:30pm PDT

Paradigm Shift in Adverse Event Report Management and Sharing: The Case, The Need, and Possible Ways Forward TBD Selective Safety Data Collection: As a Tool to Advance Clinical Trial Designs TBD Data and Technology Influence on ICH Initiatives: M4Q(r2)/Q12 and Global Harmonization TBD Navigating the Regulatory Landscape: Real-World Data and Real-World Evidence in Regulatory Documents TBD Effective Patient / Industry Collaboration: Valuing Patient Lived Experience To Inform Trial Design TBD Building Trust in New Alternative Methods in Investigational New Drug Applications TBD Innovative Alternative Approaches to Evaluating GCP During the COVID-19 Public Health Emergency and Beyond TBD Designing your Regulatory Intelligence Framework: Powered by Artificial Intelligence and Critical Thinking TBD Health Canada Town Hall TBD Impact of Accelerated Pathways on Patients in Five Countries/Regions TBD Past, Present, and Future: How Industry and FDA are Handling the Evolving Clinical Trial Diversity Regulatory Landscape TBD Data Insight Generation: Leveraging Data Visualization in Study Planning, Monitoring, Exploration, Reporting, and Submission TBD Be Creative and Innovative: A Simple Step-by-Step Process for You and Your Team TBD Elevate Leadership: Harnessing the Five Superpowers TBD

4:45pm PDT

Certara Innovation Theater: Technology-Enabled Writing - Use CoAuthor™ as your Fully Integrated GenAI Medical Writing Platform Exhibit Hall Theater #3

7:00am PDT

Coffee and Light Refreshments Sails Pavilion

8:00am PDT

Behavioral and Educational Strategies for Avoiding Falsified Medicine Exposure (BE SAFE) TBD Considerations for Identification of Drug-Induced Liver Injury TBD Feasible Site Feasibility Assessments: Rethinking Business as Usual to Reduce Burden, Timelines, and Costs for Sustainability TBD Data Standards SOS: Reducing Burnout and Navigating Through Fatigue - Part 1 TBD Wearable Sensors and Digital Health Technologies for Tracking Neurological and Neuromuscular Disorders TBD Early Engagement to Enhance the Incorporation of Patient Experience Data in Drug Development Programs and Regulatory Decision-Making TBD Early Experience with EU In Vitro Diagnostics Regulation: Performance Study Applications TBD Good Data Governance Practices: Regulatory and Industry Perspectives TBD Digital Biomarkers as Clinical Endpoints: The Road to Regulatory Acceptability TBD Leveraging New Meeting Opportunities in PDUFA VII: Experiences with Type D and INTERACT TBD PMDA Town Hall TBD Supporting Regulatory Convergence and Reliance Through a Pharmaceutical Quality Knowledge Management Capability TBD Beyond Traditional Trials: Real-World Data for External Controls, with Focus on Cancer Drug Applications TBD Unlocking Artificial Intelligence's Latest Development: Chat GPT for Beginners TBD

9:00am PDT

Coffee Break Exhibit Hall

9:15am PDT

Clario Innovation Theater: Responsibly Advancing the Use of Artificial Intelligence (AI) in Clinical Trials - Current Landscape, Common Misconceptions, and Future Opportunities Exhibit Hall Theater #1 Lokavant Innovation Theater: Prescriptive Study Planning: Optimizing Clinical Trials for Time Efficiency, Cost Savings, and Quality Exhibit Hall Theater #3 Zelta by Merative Innovation Theater: Revolutionizing Research - The Impact of Machine Learning and Automation in eClinical Platforms Exhibit Hall Theater #2

10:00am PDT

How to Compare FDA Medical Queries and Standardized MedDRA Queries with Interactive Graphics TBD Long-Term Safety of Approved Medicines: Approaches for Identifying, Characterizing, and Quantifying Delayed Adverse Events TBD External Control Arms at Scale: Multicenter, Multisource Infrastructure for External Control Arms TBD Targeting Shared Molecular Etiologies to Accelerate Drug Development for Rare Diseases TBD Challenges in Exceeding the Quality of Existing Endpoints and Approaches Using Digital Tools TBD Data Standards SOS: Reducing Burnout and Navigating through Fatigue - Part 2 TBD Regulatory Guidance and Papers on Technology Innovations TBD Effective Patient Engagement in Patient Experience Data: Practical Insights from Case Studies in Hard-to-Reach Populations TBD Improving Patient Access to Clinical Trials Through Decentralization and Flexible Design: Lessons from Oncology TBD How to Ensure Compliance in a Changing Regulatory Environment: A Regulators Perspective TBD Access Consortium and Project Orbis: Experiences from Industry and Regulatory Authorities and Recommendations for Improvement TBD Clinical Trial Enrollment Diversity: Why and How to Engage Community Health Centers TBD International Regulatory Convergence: Regulatory Science to Address Challenges Brought by Pharmaceutical Innovation TBD

11:00am PDT

Quality in Focus: Diethylene and Ethylene Glycol Challenges TBD Roundtable Discussion: Interactive Safety Graphics in the Regulatory Decision-Making Process TBD Roundtable Discussion: The State of Real-World Evidence for Regulatory Decision-Making - Views from FDA, EMA, and PMDA TBD Roundtable Discussion: Innovation in Manufacturing Globally TBD Luncheon Service Exhibit Hall Community Networking Lunch TBD

11:15am PDT

Deloitte Innovation Theater: Drug Safety Unfiltered - Why Isn’t the Needle Moving? Exhibit Hall Theater #1 UiPath Innovation Theater: AI Powered Automation - Reducing Time to Market for Life Sciences Exhibit Hall Theater #2 Professional Poster Session 2 Posters Exhibit Hall

11:55am PDT

Fortrea Innovation Theater: Teamwork Makes the Dream Work - How Partnering to Develop Practical Solutions that Address Site and Patient Challenges is Changing the Clinical Trial Landscape Exhibit Hall Theater #2 IQVIA Innovation Theater: An Ecosystem Approach to Site Tech Overload Exhibit Hall Theater #1 UBC Innovation Theater: RWD Enrichment Studies - Linking Pre and Post-Trial Data to Inform Product Strategy Exhibit Hall Theater #3

12:30pm PDT

Practical (and Real) AI and Advanced Automation in New Product Planning and Clinical Development TBD

12:35pm PDT

PCM Trials Innovation Theater: Mastering the Logistics of Mobile Visits in Global Decentralized Trials Exhibit Hall Theater #2 ProductLife Group Innovation Theater: Navigating the AI “boom” - A Methodological Framework to Create New Value Streams in your Specific Regulatory Affairs Context Exhibit Hall Theater #3

1:15pm PDT

Evidence Generation to Support Regulatory Decision-Making: Shift of the Trend over Time TBD Ensuring Inspection Readiness for Clinical Trials Using Decentralized Clinical Trial Design Features TBD Bridging Randomized Clinical Trials and Real-World Data Utilizing Data Linkage and Tokenization TBD The Evolving Role of Artificial Intelligence in the Medicinal Product Lifecycle TBD Topics Related to the Oncology Real-Time Oncology Review Process TBD Implementable Approaches to Fully Integrating Patient Engagement Across an Entire Company: Including all Clinical Trials TBD The State of Clinical Trials in 2024: Are We Making the Grade? TBD Enabling Patient Access Worldwide Including Japan or Other Countries to Innovative Drugs Through Global Development Strategy TBD FDA Rare Disease Town Hall TBD Platform Technology Designation: Opportunities and Challenges for Implementation TBD The European Clinical Trials Environment Under the Accelerating Clinical Trials (ACT EU) Initiative: Two Years On TBD International Harmonization to Support Pharmaceutical Quality and Lifecycle Management TBD Successful Strategies for Leading and Influencing Without Authority in an Evolving Digital Landscape TBD

2:15pm PDT

Roundtable Discussion: Be Creative and Innovative - A Simple Step-by-Step Decision Science Based Process for You and Your Team TBD Roundtable Discussion: Good Data Governance Practices - Regulatory and Industry Perspectives TBD Roundtable Discussion: Supporting Regulatory Convergence and Reliance Through a Pharmaceutical Quality Knowledge Management Capability TBD Refreshment Break Exhibit Hall

2:30pm PDT

Milliman IntelliScript Innovation Theater: Pre-Screening for Clinical Trials - The Revolution Starts in 3, 2, 1… Exhibit Hall Theater #1 Weave Innovation Theater: Minutes, Not Months - How to draft an efficient IND Exhibit Hall Theater #3

3:15pm PDT

Risk Management Planning- Some Twenty Years Later: Where we Started, How Far we have Come and a Modern Path Forward TBD Practical Approaches and Resources to Optimize Advocacy Group - Industry Collaborations: An Update on the PALADIN Consortium TBD Exploiting Real-World Data From Social Media in Patient-Focused Drug Development TBD Something Borrowed Something New for Effective Project Management: Adopting Different Thinking Approaches and New Technologies in Life Science Project Management TBD Strategies to Make your Clinical Trials More Inclusive for Patients with Disabilities TBD Advancing Innovation in Clinical Trial Design and Conduct TBD For Whom the Cell Tolls: Ethics in the Era of Precision Medicine TBD How Will the Increasing use of Real-World Evidence for Regulatory Decision-Making Impact QA Strategies and GCP Inspections? TBD How to Provide Necessary Medicinal Products to Children? TBD This is Your Pilot Speaking: The Journey from Regulatory Pilot Program Innovation to Routine Practice TBD Evolution of Electronic Product Information in LATAM: Challenges and Opportunities to Improve the Value of Healthcare TBD Regulatory Policy Roundtable: Pharmaceutical Quality, Generics, Innovative Medicines TBD Securing the Chain: US and EU Legislative Reforms and Regulatory Actions for Drug Shortage Mitigation TBD The Promise of Disease Progression Modeling to Bring Treatments to Patients Sooner TBD

4:30pm PDT

FDA's Approach in Harmonize Surveillance for Drugs and Biologics Safety and Quality Data TBD Regulatory, Pharmacoepidemiologic, and Pharmacovigilance Considerations Related to the Safety of Drugs Used During Pregnancy TBD Collaboration in an Expanding Regulatory Landscape for Pharmacovigilance TBD Innovation, Agility, and Accessibility in Trial Execution: Exploring the Roles, Pathways, and Potential for Integration of Embedded Clinics, Retail Pharmacies, and Diagnostic Providers in Clinical Research at S... TBD Harnessing Real-World Evidence in Regulatory Decision-Making: Update on DARWIN EU, Use of Real-World Evidence in New Applications in the EU TBD Shame and Blame: Our Words are a Barrier to Clinical Research are a Care Option TBD Accelerating Innovation Through Design: Integrating Real-World Data into Clinical Trials TBD ANVISA Town Hall TBD Middle East Town Hall Room 6D Recent Evolution of Accelerated Approval Pathways: Impacts on the Pathways Use and Implementation TBD Remote Regulatory Assessments: Examining Another Tool in the FDA Regulatory Toolbox TBD Post-COVID cGMP Inspections by Global Regulatory Authorities TBD Charting the Biosimilars Beat Drop: The Latest Updates in the Biosimilars Landscape, Coverage, and Adoption in the US TBD The Value of Project Management in Driving Drug Discovery Success: A Comparison Between Small Versus Large Pharmaceutical Companies TBD

7:00am PDT

Coffee and Light Refreshments Sails Pavilion

8:00am PDT

Risk Minimization in the EU: New Guidance, New Collaborations TBD How Common Data Models Can Address the Challenges in the Use of Clinical Trial and Real-World Data for Evidence Generation TBD Synergizing Large Language Models and Digital Health Technology for Healthcare Transformation TBD All the Ways Medical Affairs Supports Product Development: From Clinical Trials to Product Launch TBD Which Clinical Outcome Assessment to Choose: Questionnaire or Sensor? Time to Align an Endpoint Selection Framework TBD Have a Safe Trip: Clinical and Patient Alignment in Clinical Trials with Psychedelics TBD Unlocking Innovation: Implementing Future-Focused Risk-Based Quality Management Quality Briefs - A Cross-Functional Challenge TBD Australia, Canada, Singapore, Switzerland, and United Kingdom Consortium (Access): Re-Imagining Regulatory Collaboration TBD FDA Oncology Center of Excellence: Are Sponsors Taking Full Advantage of OCE Regulatory Policy “Projects?” TBD WHO Town Hall: Safeguarding Public Health - WHO's Vision for Global Regulatory Excellence TBD Partnering with Regulatory Authorities to Unlock the Value in Digital Health Products TBD Revolutionizing Regulatory CMC and Advanced Manufacturing with the Power of AI: Unleashing Innovation and Efficiency TBD The Future of Women’s Health: Do We Really Want Innovation? Policy Ideas To Advance Innovation, Access, and Novel Approaches TBD

9:00am PDT

Coffee Break Exhibit Hall

9:15am PDT

ArisGlobal Innovation Theater: Unleashing the Power of Automation and Understanding the Promise of GenAI in Pharmacovigilance and Regulatory Affairs Exhibit Hall Theater #2 IQVIA Innovation Theater: Pre-Approval Access - Strategies for Providing Investigational Product to Patients Beyond Clinical Trials Exhibit Hall Theater #1

10:00am PDT

Unlocking the Potential of Pharmacogenomics for Reducing the Burden of Adverse Drug Reactions TBD Unlocking the Potential of IDMP for Global Exchange of Medicinal Products Data TBD AI Process in Medical Writing, AI Utilization, and AI Real-World Use Cases TBD The ChatBot Will See You Now: Ethical Considerations in Incorporating AI into Informed Consent TBD Defining an Inclusive Clinical Trials Approach in Europe TBD Driving Capacity Building, Equity, and Geographic Expansion in Clinical Trials TBD Bringing Transformational Treatments to Patients: Regulatory Convergence and Reliance on Cell and Gene Therapy Products TBD Leveraging Testing Results Generated Within Treating Hospitals for Trials Across the Globe TBD Using Data Analytics for Good Pharmacovigilance Practices TBD A Paradigm Shift in Global Regulatory Reviews: Has the New Normal Arrived? TBD Enabling Innovation and Regulatory Agility to Address Sustainability, Environment, and Climate Goals TBD Pioneering New Frontiers: Advanced Drug Delivery Technologies and Cell/Gene Therapies in Combination Products TBD

11:00am PDT

Roundtable Discussion: The Evolving Role of Artificial Intelligence in the Medicinal Product Lifecycle TBD Roundtable Discussion: AI Process in Medical Writing, AI Utilization, and AI Real-World Use Cases TBD Roundtable Discussion: Securing the Chain - US and EU Legislative Reforms and Regulatory Actions for Drug Shortage Mitigation TBD Luncheon Service Exhibit Hall

11:15am PDT

Emerging Standards for Novel Excipients TBD

11:45am PDT

Informing Clinical Trials with Patient Feedback Through Simulations: An Innovative Methodology TBD

12:30pm PDT

Real-World Evidence (RWE) for Regulatory and Health Technology Assessment (HTA) Decision Making – Where are we? TBD

1:15pm PDT

Leveraging Point of Care Technologies for Near Real Time, Interactive Safety Surveillance: Opportunities and Challenges TBD Regulatory Considerations in Trial Design for Cell and Gene Therapies TBD Artificial Intelligence in the Drug Development Lifecycle: Opportunities and Challenges in Regulatory Operations TBD Challenges and Solutions to Building the Right Patient-Centered Evidence to Support Fit-For-Purpose Sensor-Based Outcomes TBD A Clinical Research Workforce in Crisis: Imperatives for a Sustainable Staffing Model TBD Revolutionizing Quality Management: Harnessing the Power of AI for Enhanced Decision Making and Continuous Improvement TBD Applying Machine Learning and Artificial intelligence for Predicting Product Profile Approvability (PoPPA) TBD ICH M15 Model Informed Drug Development: Steps Toward Harmonized Guidance TBD ICMRA Post-Pandemic: Regulators Looking into the Future TBD Study Design for Cell and Gene Therapy Trials: Regulatory Overview, Challenges, and Updates TBD ICH Efforts to Incorporate Patient’s Perspective to Enhance Quality, Relevance, Safety and Efficacy of Drug Development TBD Unlocking the Puzzle of Borrowing Adult Data for Designing Innovative Hybrid Pediatric Trials TBD

2:15pm PDT

Roundtable Discussion: The Chatbot Will See You Now - Ethical Considerations in Incorporating AI in Informed Consent TBD Roundtable Discussion: Leveraging Cloud-Based Technologies to Accelerate Reliance and Convergence - An Industry and Regulatory Agency Experience TBD Refreshment Break Exhibit Hall

2:30pm PDT

RBQM (Risk-Based Quality Management): What Topics Should be Discussed with Whom in the Room? TBD

3:15pm PDT

A Safety Surveillance Plan for Serious Anticipated Events TBD Streamlining Processes and Data Exchange Across R&D Functions to Improve Performance and Facilitate Automation TBD More than Meets the Eye: AI’s Potential to Identify Skin Manifestations of Internal Disease in Patients of Color TBD Implementing Changes To Drug-Device Combination Products Globally TBD Unlocking Success: Mastering the Pharmaceutical Asset Lifecycle Journey TBD EMA Town Hall TBD Embedding Diversity and Inclusion into Global Clinical Research: Where Have we Been and Where are we Going? TBD The Intersection of Patient-Experience Data and Benefit-Risk Analysis TBD Harnessing the Power of Artificial Intelligence (AI) in Clinical Research From Knowledge Graphs to Generative AI TBD Recruitment Optimization in Clinical Trials: Looking Towards an Adaptive Future TBD Improving Communication Across Differences in Drug Development Teams TBD

4:30pm PDT

Critical Appraisal of Artificial Intelligence Solutions for Pharmacovigilance TBD Leveraging Cloud-Based Technologies to Accelerate Reliance and Convergence: An Industry and Regulatory Agency Experience TBD Patient-Centric Approaches in Summaries and Data Return TBD Using Influencers to Recruit Hard-to-Engage Populations TBD Sustainability of Rare Disease Drug Development TBD Updated Status of Multiregional Clinical Trials Based on ICH E17 Guideline: 5 Years After the Implementation TBD Challenges in Quality Control for Cell and Gene Therapy Development: Regulatory Perspectives and Best PracticesPerspectives and Best Practices TBD Industry and Regulatory Experience in Implementing The E9(R1) Estimand Framework TBD From X to Z: Unleashing the Power of Multigenerational Collaboration in Life Sciences – The Basics for All TBD

7:00am PDT

Coffee and Light Refreeshments Sails Pavilion

8:00am PDT

Harnessing Real-World Data to Generate Real-World Evidence for Regulatory Grade Safety Studies TBD Leveraging Statistical Approaches in Drug Safety Analysis TBD Harnessing Generative AI to Translate Questions into Insights TBD Meeting in the Middle: Best Practices for Collaboration Between Medical Affairs and Clinical Development TBD Achieving Diversity in Clinical Research Using Digital Health Technologies TBD More Nuanced Clinical Outcomes from Person-Generated Health Data: The New Frontier TBD Targeting Hope for Oncology Patients: Perceptions and Considerations for Genetic Testing and Precision Medicine TBD Dive into the Power of Diversity: Leveraging Transferable Skills from Regulated Industries to Regulatory Agencies in Medicines Development TBD The FDA's Commitment to Patient-Centric Research: Key Themes from Decentralized Trial Draft Guidance TBD

9:15am PDT

Generative AI-Driven Clinical Data Management: A Myth or a Reality? TBD The Impact of Racial Discrimination on the Patient Clinical Trial Experience TBD Unleashing Biopharma Potential: Maximizing Consortia Engagement with Strategic Change Management TBD Regulatory Affairs of the Future: Is Now TBD What is the Value of Reference Agency Assessment Reports in Enabling Reliance and What do Relying Agencies Require? TBD EMA-FDA Question Time TBD

10:15am PDT

Coffee Break Ballroom 6 Lobby

10:45am PDT

FDA Town Hall TBD